BMC Medicine is a prestigious, peer-reviewed journal published by BMC, specializing in the rapidly evolving field of medicine. Launched in 2003, this journal has consistently operated under an Open Access model, ensuring that groundbreaking research is freely accessible to the global community. With an impressive impact factor, BMC Medicine holds a distinguished Q1 ranking in the field of Medicine (miscellaneous) and ranks #29 out of 636 in General Medicine according to Scopus, placing it in the top 95th percentile of its category. This journal is dedicated to disseminating high-quality research that advances the understanding and practice of medicine, with a comprehensive focus that includes clinical research, public health, and health policy. As part of its commitment to fostering innovation and collaboration in healthcare, BMC Medicine invites researchers, professionals, and students to contribute to this vital platform that addresses the most pressing medical challenges of our time.

STAR Protocols, published by Elsevier, is an esteemed open access journal that has been at the forefront of providing innovative experimental protocols since its inception in 2020. With a distinct focus on a range of scientific disciplines including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, this journal serves as a vital resource for researchers, professionals, and students alike. The journal holds a commendable status, reflected by its Q1 and Q2 rankings across various relevant categories, ensuring the dissemination of high-impact research methods and findings. With its open access format, STAR Protocols encourages a broad readership and facilitates the sharing of pivotal knowledge in the scientific community, driving forward the culture of transparency and collaboration in research. Positioned in the vibrant academic landscape of the United States, it steadily contributes to the evolution of experimental methodologies, fostering innovation across disciplines.

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

BIOMEDICAL RESEARCH-TOKYO is an esteemed interdisciplinary journal published by BIOMEDICAL RESEARCH PRESS LTD, dedicated to disseminating pioneering research and advancements in the fields of biochemistry, genetics, and medicine. Since its inception in 1980, the journal has established itself as a reputable source of knowledge, contributing significantly to the global scientific community with its strong emphasis on innovative findings and methodologies. With a consistent presence in the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it continues to attract a diverse range of research articles. While the journal does not operate as an open access platform, it remains an essential resource for researchers, professionals, and students seeking to further their understanding of biomedical sciences. Located in Sapporo, Japan, this journal fosters collaboration and knowledge sharing among the international biomedical research community, engaging readers through its compelling studies that span from 1980 to 2024.

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Methods and Protocols is a prestigious open-access journal published by MDPI, focusing on the critical domain of biochemistry, genetics, molecular biology, and biotechnology. Launched in 2018 and based in Basel, Switzerland, the journal provides a vital platform for sharing innovative methodologies and experimental protocols that advance scientific research and development. With an impressive Q2 ranking in multiple categories, including Biochemistry, Genetics and Molecular Biology, and Biotechnology, it fosters a collaborative environment for researchers and professionals to disseminate their findings. With a mission to enhance reproducibility and transparency in scientific inquiry, Methods and Protocols not only serves as an essential resource for academia but also contributes to the practical application of research in various industries. The journal's open-access model ensures that cutting-edge research is accessible to a global audience, thus promoting knowledge sharing and inspiring future innovations within the scientific community.

Libyan Journal of Medicine, published by TAYLOR & FRANCIS LTD, is a prominent open-access journal dedicated to advancing the field of medicine, particularly within the context of Libyan and broader Mediterranean health challenges. Since its inception in 2006, the journal has facilitated the dissemination of vital research findings, offering unrestricted access to its rich repository of knowledge, which enhances visibility and accessibility for researchers, clinicians, and students alike. Ranking in the Q3 category within the Medicine (miscellaneous) sector for 2023, and positioned at Rank #147 out of 636 in the general medicine category on Scopus, it reflects a notable recognition for its contributions to medical research. The journal aims not only to publish high-quality articles that span a variety of medical disciplines but also to foster collaboration and communication among the international medical community. As it converges its focus from 2009 to 2024, the Libyan Journal of Medicine serves as an invaluable resource for cutting-edge research and innovative medical practices.

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

The Journal of Istanbul Faculty of Medicine (Istanbul Tip Fakultesi Dergisi), published by ISTANBUL UNIVERSITY, FACULTY OF MEDICINE, is an esteemed open-access journal that has been committed to disseminating significant medical research since becoming open access in 2017. As a platform for transformative scholarly work, this journal is situated in Turkey and actively engages with diverse medical disciplines to contribute to the collective understanding of health and medicine. Featuring a range of studies that span various facets of medical science, the journal is categorized within the Q4 quartile in Medicine (miscellaneous) for 2023, with its Scopus rankings placing it at #586 out of 636 in the General Medicine category, marking it as a resource that is gaining traction within the academic community. This journal aims to serve as a vital resource for researchers, healthcare professionals, and students alike, fostering the exchange of ideas and innovation in medicine. By providing public access to its content, it underscores the importance of open science in enhancing knowledge sharing and collaboration across borders. For those interested in advancing their research and professional development, the Journal of Istanbul Faculty of Medicine is an invaluable tool for staying informed on the latest findings and discussions in the medical field.

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.